Immucell (ICCC) Stock Statistics & Valuation Metrics

Immucell has a market cap or net worth of $87.57M. The enterprise value is $98.60M.

Immucell has 9,046,799 shares outstanding. The number of shares has decreased by -2.65% in one year.

Immucell’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 4.10%.

The current PE Ratio of Immucell is ―. Immucell’s PEG ratio is 0.99.

In the last 12 months, Immucell had revenue of 27.64M and earned -1.04M in profits. Earnings per share was -0.12.

In the last 12 months, operating cash flow was 4.47M and capital expenditures -1.10M, giving a free cash flow of 3.38M billion.

Immucell pays an annual dividend of ―, resulting in a dividend yield of ―

Immucell upcoming earnings date is Aug 19, 2026, After Close (Confirmed).

Immucell as a current ratio of 4.26, with Debt / Equity ratio of 43.86%

In the past 12 months, Immucell has paid 11.57K in taxes.

Immucell EV to EBITDA ratio is 30.32, with an EV/FCF ratio of 52.98.

Immucell has $6.81M in cash and marketable securities with $12.78M in debt, giving a net cash position of -$5.96M billion.

Gross margin is 42.59%, with operating margin of 5.97%, and net profit margin of -3.76%.

The average price target for Immucell is ―, which is 11.43% higher than the current price. The consensus rating is ―